Healthcare
Emcure Pharmaceuticals Limited (EMCURE)
Emcure Pharmaceuticals Limited (EMCURE) is an NSE-listed Healthcare company. latest close ₹1,922.4, 1-day return -0.8%, 1-week return -1.9%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 5 Oct 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹1,922.4
- 1-day return
- -0.8%
- 1-week return
- -1.9%
- 1-month return
- -0.3%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 38.1
- ADX (14)
- 8.7
- ROC 10
- -4.3%
- vs 52W high
- -8.5%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹36,690 Cr
- P/E
- 36.3
- P/B
- 7.41
- ROE
- —
- D/E
- 30.57
- Net margin
- 10.4%
- Rev. growth YoY
- 22.9%
- Div. yield
- 19.0%
- 52W high
- ₹2,100.7
- 52W low
- ₹1,306.5
- EPS (TTM)
- ₹53.28
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return -0.8%
Latest 1-day price change versus the previous close.
- signal
1-week return -1.9%
Price change over the last five trading sessions.
News & screener mentions
Recent QUANTSCASE daily posts that listed EMCURE.
No recent screener posts mentioned EMCURE yet. New daily posts will show up here automatically.
